Published in Obesity and Diabetes Week, April 4th, 2005
The company president said that new regulatory policies in Mexico require that any advertising that makes medical claims must have prior approval from the Mexican national regulator.
The company's diabetes drug, Sucanon, which has been approved for the treatment of symptoms of type 2 diabetes, is now sold in more than 600 stores nationally in Mexico, including outlets of at least 4 drugstore chains.
Biotech Holdings Ltd.'s head...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.